Trials / Unknown
UnknownNCT01100814
Expression of S100A2 and Trefoil Factor Family Members in Epstein-Barr Virus Related Gastric Cancer
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- —
- Sponsor
- National University Hospital, Singapore · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The investigators hypothesize that aberrant hypermethylation of tumour suppressor genes is an important mechanism for Epstein-Barr Virus (EBV) - related gastric carcinogenesis, the promoter hypermethylation status and the expression of S100A2 and TFF1 might be different between EBV-associated gastric cancer (GC) and non EBV-associated GC.
Conditions
Timeline
- Start date
- 2011-09-01
- Primary completion
- 2014-12-01
- Completion
- 2014-12-01
- First posted
- 2010-04-09
- Last updated
- 2014-01-22
Locations
1 site across 1 country: Singapore
Source: ClinicalTrials.gov record NCT01100814. Inclusion in this directory is not an endorsement.